Artist
The Cure
Alternative rock · United Kingdom · 1978
high confidence
Estimate at a glance
How much money does The Cure make?
The Cure is estimated at $550K-$2.2M/year on the artist side, with gross catalog revenue and ownership context separated below.
Takeaway: The Cure works as a durable earnings page because the artist-side estimate, ownership context, and gross catalog framing can all be separated cleanly.
Conservative modeled artist-side annual earnings: $550K-$2.2M/year.
What stands out
- Currently ranks around the top 78% of reviewed artists by estimated artist-side earnings
- Active since 1978 and still commercially relevant roughly 48 years later
- 3 top songs anchor this estimate
- Alternative rock remains the clearest genre lane for this catalog
- high confidence estimate
Why the catalog still earns
- Catalog streaming sustains earnings after the original release cycle ends.
- Playlist use and rediscovery keep durable songs in circulation.
- Licensing and long-tail audience demand extend catalog value over time.
The Cure lands in the top 78% of tracked artists by estimated artist-side earnings.
artist-side split is modeled + gross catalog revenue is separated. Why?
The primary figure is the modeled artist-side or estate-side annual cut, not gross catalog revenue.
The Cure's dark-pop and alternative staples continue to perform through touring, nostalgia, and playlist placement.
Artist image source: Wikimedia Commons
How It Compares
The Cure is compared against nearby artists in the catalog based on genre, country, era, and modeled earnings range.
Revenue Breakdown
Bars reflect modeled annual midpoint ranges, not audited royalty statements.
Reader questions about The Cure
How much does The Cure make in a year?
The Cure is estimated at $550K-$2.2M/year on the artist side, with gross catalog revenue and ownership context separated below.
Why does The Cure still make money?
Catalog streaming sustains earnings after the original release cycle ends. Playlist use and rediscovery keep durable songs in circulation. Licensing and long-tail audience demand extend catalog value over time.
Who controls The Cure's catalog?
The Cure's page should be read as modeled artist-side annual income, not a public royalty statement. Ownership and label terms can materially change take-home economics.
Show ownership and assumptions
The Cure's page should be read as modeled artist-side annual income, not a public royalty statement. Ownership and label terms can materially change take-home economics.
Supporting Revenue Context
Assumptions: Estimate keeps The Cure's current headline range as the artist-side figure and models gross catalog, label, publishing, and writer lanes from that conservative annual range.
Ownership and Catalog Status
Notes: The Cure's page should be read as modeled artist-side annual income, not a public royalty statement. Ownership and label terms can materially change take-home economics.
Split-aware estimate
The primary figure is the modeled artist-side or estate-side annual cut, not gross catalog revenue.
More Context
Related Artists
Key Career Highlights
Editorial Insight
Songs like Friday I'm in Love and Just Like Heaven still help define the catalog's long-tail earnings profile.